Thank you! To @uretericbud and the FCCC team. Very meaningful to get to spend time back with great friends and mentors. Outstanding group of fellows and residents. Super fun visit.

So special to host @SBoorjian, Chair of @MayoUrology, as the Judith & Thomas Leidy Visiting Professor. One of the greatest minds in urology with deep historic and personal ties to @FCUroOnc. Have learned so much from Steve over the years - this visit was no exception!

It was an honor to visit @FCUroOnc and discuss the surgical management of IVC tumor thrombus with some of the brightest minds in the field. Grateful for the warm welcome and great conversation.

Huge Thank You to @rezanab for coming up from @DukeUrology to present today at @FCUroOnc Grand Rounds, giving an incredible lecture on IVC tumor thrombectomy. Proud to have learned from him @emory_urology and now to see him doing such huge things in practice.

SUO 2025

Are you applying for a @UroOnc fellowship this year and interested in learning more about the @DukeUrology SUO program? Our team will be at #SUO2025 and excited to connect! DM us with any questions! @michaelabern @AnkeetShahMD @rezanab @mbrothberg @JuddMoul @Refugia_UroMD

Honored to present my first talk at the AUA! Grateful for the opportunity to share our work and to learn from so many inspiring colleagues.@AmerUrological #AUA2025

In this @urogoldjournal article, "Renal Cell Carcinoma with Venous Tumor Thrombus Has a Predilection for the Lungs" @vidit_sharma_ @SBoorjian @HThompsonMD @BradLeibovichMD @flscientist @rezanab & @UroR_Pessoa share results in this comprehensive study. #RCC https://t.co/msSk9hhgla

📢 Attention @UroOnc applicants! The @MayoUrology Urologic Oncology Fellowship in Rochester, MN is now open for applications for the 2026 match. 🗓️Application Deadline: February 1, 2025 Apply here: https://t.co/2lLu5RdvYq @SUO_YUO

Feel free to reach out if you have any questions about the program. @michaelabern @AnkeetShahMD @JuddMoul @mbrothberg @ThomasPolascik @rezanab @UroOnc @SUO_YUO @DukeGUCancer @DukeUrology @AmerUrological

Thank you so much to the @SUO_YUO and to my mentors for the continued guidance and support - TEAM effort above all

Happy Halloween 🎃 from @DukeGUCancer @DukeUrology! My new practice partner @DukeCancer @rezanab Dr Reza Nabavizadeh and I share a workroom in clinic every Thursday. @DukeUroRes

It's bittersweet to wrap up the @SUO_YUO fellowship & say goodbye to @MayoUrology. This incredible experience has been a true privilege 🙏. Looking forward to lifelong friendships and mentorships with the amazing people I've met. Excited to start my new journey at @DukeUrology!

Thank you @MayoUrology for an incredible year! Was a privilege to learn from you and train under your guidance as @SUO_YUO fellow. So grateful for your mentorship and support. Can’t believe life as a trainee is over, but ready to begin the next step! @UMichUrology I’M BACK!

Our new study in @NatureComms is published! Given the heterogeneous and multifocal nature of primary, localized PCa, we sought to identify the ‘biologically dominant’ clone or focus that gives rise to metastasis in the lymph nodes. 🔬 https://t.co/uXM7on1AhO

Apparently these things need to be clarified for the media and Israeli audiences: - Iranians are not an Arab people - The language of Iran is Farsi not Arabic - Iran did not launch a war on Israel, the Islamic Republic did - The majority of the Iranian people hate the

As an Iranian I strongly condemn the drone and missile attack by Islamic regime against Israel. Now, there is no excuse for the EU not to designate the Islamic Republic Revolutionary Guards as a terrorist organization. This regime is causing massive suffering in the region. Iran

The 340B Drug Pricing Program and oral specialty drugs for advanced prostate cancer. | Journal of Clinical Oncology

Excellent session on the Shortage of Drugs for Urothelial Carcinoma chaired by @RuchikaTalwarMD 👏 👏👏 #guasco24

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive #NMIBC. @SBoorjian @MayoClinic joins @UroDocAsh @MDAndersonNews to discuss this novel therapy, nuances and updated trial results, in a conversation on UroToday > https://t.co/NTlBWrrmLq